针对癌症治疗的超声响应纳米载体:生理化学特征导向设计
Feijuan Yuan1, Dan Peng1, Man Lu1
1Department of Ultrasound Medicine, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Institute, Hospital & Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China; Department of Ultrasound Medicine, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
概括
超声响应纳米载体 (URN) 通过利用物理化学特性来控制药物输送,提供精确的癌症治疗. 克服安全性,准性和标准化的挑战是临床翻译的关键.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
- 在瘤学瘤学.
背景情况:
- 超声响应纳米载体 (URN) 对于先进的癌症治疗至关重要.
- 它们的设计利用物理化学性质来针对药物输送.
- 多种纳米载体平台包括脂质体,聚合物,纳米泡和MOF.
研究的目的:
- 审查URN设计中的结构-属性-功能相关性.
- 分析声响应的物理化学决定因素.
- 提出推进URN向临床翻译的路线图.
主要方法:
- 系统评估URN设计原则.
- 对影响美国响应能力的物理化学性质的分析.
- 审查URN发展当前的局限性和挑战.
主要成果:
- 通过US刺激,URN可实现时空药物递送,增强瘤透,并产生协同效应.
- 美国诱导的效应促进了多式疗法,如基因传递和化学声动疗法.
- 主要挑战包括药理动力学,生物安全性,准效率,参数标准化和制造.
结论:
- 解决安全,定位,标准化和制造方面的挑战对于URN临床翻译至关重要.
- 整合计算建模,刺激响应材料和人工智能可以推进下一代URN.
- 未来的方向重点是个性化瘤学和URN的成功临床应用.
相关概念视频
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...